- Home
- IXHL vs GNTA Comparison
IXHL vs GNTA Comparison
Compare IXHL & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IXHL | GNTA |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | Australia | Italy |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.6M | 34.0M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | IXHL | GNTA |
|---|---|---|
| Price | $5.95 | $0.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.1M | 59.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.11 | $0.71 |
| 52 Week High | $5.45 | $10.00 |
Technical Indicators
Market Signals| Indicator | IXHL | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 90.18 | 42.82 |
| Support Level | $0.31 | $0.71 |
| Resistance Level | N/A | $1.70 |
| Average True Range (ATR) | 0.37 | 0.09 |
| MACD | 0.40 | 0.01 |
| Stochastic Oscillator | 91.05 | 31.33 |
Price Performance
Historical ComparisonAbout IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.